Clinical Trials Directory

Trials / Unknown

UnknownNCT04657133

Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage

The Safety and Efficacy of Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage: A Multicenter, Randomized, Controlled Study

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
452 (estimated)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Intracerebral hemorrhage (ICH) results from the rupture of small vessels damaged by chronic hypertension, amyloid angiopathy or other disease. Currently, ICH has been a devastating type of stroke that lacking effective therapy. Remote ischemic conditioning (RIC), a systematically protective strategy, has been found to have neuroprotective effects by in patients with ischemic stroke. In addition, animal studies show that RIC is safe in ICH model and it could accelerate the absorption of hematoma. In a previous clinical study (RICH-1), RIC have been found to be safe and well-tolerated in patients with ICH. Therefore, the investigators plan to undertake this study to further evaluate the safety and efficacy of RIC in patients with ICH. The investigators hypothesize that treatment with RIC will accelerate the absorption of hematoma and improve patients' functional outcomes. Results of this study can potentially bring into account new means to improve the outcomes of ICH patients.

Conditions

Interventions

TypeNameDescription
DEVICERemote ischemic conditioningRIC is a non-invasive therapy that performed by an electric autocontrol device with cuff placed on arm. RIC procedures consist of five cycles of 5-min inflation (200 mmHg) and 5-min deflation of cuff on one arm. The procedure will be performed once daily for consecutive 7 days after enrollment.
DEVICESham remote ischemic conditioningSham RIC will be performed by the same electric autocontrol device with cuff placed on arm. Sham RIC procedures consist of five cycles of 5-min inflation (30 mmHg) and 5-min deflation of cuff on one arm. The procedure will be performed once daily for consecutive 7 days after enrollment.
DRUGStandard medication therapyStandard medication therapy will be performed according to the national and international guidelines.

Timeline

Start date
2021-04-22
Primary completion
2022-12-31
Completion
2023-06-30
First posted
2020-12-08
Last updated
2022-07-19

Locations

13 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04657133. Inclusion in this directory is not an endorsement.